title: Kidney cancer: targeting FGF for third-line treatment of mRCC.
authors.forename: Sarah
authors.initials: S
authors.lastname: Payton
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D009536:Niacinamide / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D015363:Quinolones / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001562:Benzimidazoles; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors; D015363:Quinolones; D009536:Niacinamide